Company / EPS (Diluted)
Lucid Diagnostics Inc. EPS (Diluted) History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.26
FY2024
5-year range
-$1.55 / -$0.59
FY2021-FY2024
Trend
+18.7%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-0.59 to $-1.26 over the past 3 years.
Based on SEC 10-K filings.
-1.26 in FY2024.
Declined from $-0.59 to $-1.26 over the past 3 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, eps (diluted) increased 18.7% year-over-year.
Company context
Key Data Points
- Altman Z-Score -4.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$1.26 | +18.7% |
| FY2023 | -$1.55 | - |
| FY2022 | - | - |
| FY2021 | -$0.59 | - |
As of FY2024 · SEC 10-K Annual Filings · Updated Jun 24, 2026